PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extract of bark (400 mg/kg) significantly inhibited carrageenan-, dextran-, and histamine-induced hind paw edema in rats [PMID:20645819].
Ethanol and ethyl acetate extracts significantly reduced fasting blood glucose levels in streptozotocin-induced diabetic rats [PMID:22435475, PMID:22593683].
Methanol stem bark extract (125-500 mg/kg) provided hepatoprotection against CCl4-induced damage by decreasing serum enzymes (SGOT, SGPT, ALP) and bilirubin [PMID:20645794].
Methanolic extract (125-500 mg/kg) improved behavioral activity and muscular coordination in 6-OHDA induced rat models [PMID:23248404].
Methanol extract (125-500 mg/kg) demonstrated neuroprotective activity in a global cerebral ischemia rat model [PMID:23607907].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 31734448 (2020) — Attenuation of adjuvant-induced arthrits by Stereospermum colais and Stereospermum suaveolens via modulation of inflammatory mediators. · Journal of ethnopharmacology
- 2.PMID: 25598634 (2015) — Cycloolivil, a lignan from the roots of Stereospermum suaveolens. · Pharmacognosy research
- 3.PMID: 23607907 (2013) — Neuroprotective activity of Stereospermum suaveolens against global cerebral ischemia rat model. · Pharmaceutical biology
- 4.PMID: 20645819 (2010) — Anti-inflammatory effect of Stereospermum suaveolens ethanol extract in rats. · Pharmaceutical biology
- 5.PMID: 29564534 (2018) — Green synthesis of Stereospermum suaveolens capped silver and gold nanoparticles and assessment of their innate antioxidant, antimicrobial and antiproliferative activities.